ResearchMoz

Mexico Cardiovascular Devices Market Outlook to 2016

Publisher Name » GlobalData
Published Date » 2010-05-31
No. Of Pages » 195

GlobalDatas medical equipment report, Mexico Cardiovascular Devices Market Outlook to 2016 provides key market data on the Mexico cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Market size and company share data for seven cardiovascular devices market categories Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. 
  • 2009 company shares and distribution shares data for each of the seven market categories.
  • Global corporate-level profiles of key companies operating within the Mexico cardiovascular devices market.
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical Inc., Cordis Corporation., Abbott Laboratories, Terumo Corporation and C.R. Bard, Inc.
Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Mexico cardiovascular devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table Of Contents

1 Table of Contents 2
1.1 List of Tables 12
1.2 List of Figures 15

2 Introduction 16
2.1 What is This Report About? 16

3 Cardiovascular Devices In Mexico 17
3.1 Cardiovascular Devices, Market Segmentation 17
3.2 Cardiovascular Devices, Mexico, Overall Revenue ($m), 2002-2016 18
3.3 Cardiovascular Devices Market, Mexico, Revenue Mix ($m), 2009 19
3.4 Cardiovascular Devices Market, Mexico, Category Contribution (%), 2009 20
3.5 Cardiovascular Devices, Mexico, Category Volume (Units), 2002-2016 26
3.6 Cardiovascular Devices, Mexico, Company Share (2008-2009) 31

4 Cardiac Rhythm Management In Mexico 33
4.1 Cardiac Rhythm Management, Market Segmentation 33
4.2 Cardiac Rhythm Management Market, Mexico, Revenue Mix ($m), 2009 34
4.3 Cardiac Rhythm Management Market, Mexico, Category Contribution (%), 2009 35
4.4 Cardiac Rhythm Management Overall Revenue (2002-2016) 36
4.4.1 Cardiac Resynchronisation Therapy Revenue (2002-2016) 39
4.4.2 Implantable Cardioverter Defibrillator Revenue (2002-2016) 41
4.4.3 Pacemaker Revenue (2002-2016) 43
4.4.4 External Defibrillator Revenue (2002-2016) 45
4.5 Cardiac Rhythm Management Overall Volume (2002-2016) 47
4.5.1 Cardiac Resynchronisation Therapy Volume (2002-2016) 49
4.5.2 Implantable Cardioverter Defibrillator Volume (2002-2016) 51
4.5.3 Pacemaker Volume (2002-2016) 53
4.5.4 External Defibrillator Volume (2002-2016) 55
4.6 Cardiac Rhythm Management Average Price (2002-2016) 57
4.7 Cardiac Rhythm Management Distribution Share (2008-2009) 59
4.8 Cardiac Rhythm Management, Mexico, Company Share (2008-2009) 60

5 Cardiovascular Monitoring and Diagnostic Devices In Mexico 62
5.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 62
5.2 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue Mix ($m), 2009 63
5.3 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Category Contribution (%), 2009 64
5.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2002-2016) 65
5.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2002-2016) 68
5.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2002-2016) 70
5.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2008-2009) 71
5.8 Cardiovascular Monitoring and Diagnostic Devices, Mexico, Company Share (2008-2009) 72

6 Cardiovascular Prosthetic Devices In Mexico 74
6.1 Cardiovascular Prosthetic Devices, Market Segmentation 74
6.2 Cardiovascular Prosthetic Devices Market, Mexico, Revenue Mix ($m), 2009 75
6.3 Cardiovascular Prosthetic Devices Market, Mexico, Category Contribution (%), 2009 76
6.4 Cardiovascular Prosthetic Devices Overall Revenue (2002-2016) 77
6.4.1 Cardiac Assist Devices Revenue (2002-2016) 79
6.4.2 Prosthetic Heart Valve Revenue (2002-2016) 81
6.5 Cardiovascular Prosthetic Devices Overall Volume (2002-2016) 83
6.5.1 Cardiac Assist Devices Volume (2002-2016) 85
6.5.2 Prosthetic Heart Valve Volume (2002-2016) 87
6.6 Cardiovascular Prosthetic Devices Average Price (2002-2016) 89
6.7 Cardiovascular Prosthetic Devices Distribution Share (2008-2009) 90
6.8 Cardiovascular Prosthetic Devices, Mexico, Company Share (2008-2009) 91

7 Cardiovascular Surgery In Mexico 92
7.1 Cardiovascular Surgery, Market Segmentation 92
7.2 Cardiovascular Surgery Market, Mexico, Revenue Mix ($m), 2009 93
7.3 Cardiovascular Surgery Market, Mexico, Category Contribution (%), 2009 94
7.4 Cardiovascular Surgery Overall Revenue (2002-2016) 95
7.4.1 Perfusion Disposables Revenue (2002-2016) 97
7.5 Cardiovascular Surgery Overall Volume (2002-2016) 99
7.5.1 Perfusion Disposables Volume (2002-2016) 101
7.6 Cardiovascular Surgery Average Price (2002-2016) 103
7.7 Cardiovascular Surgery Distribution Share (2008-2009) 104
7.8 Cardiovascular Surgery, Mexico, Company Share (2008-2009) 105

8 Electrophysiology In Mexico 106
8.1 Electrophysiology, Market Segmentation 106
8.2 Electrophysiology Market, Mexico, Revenue Mix ($m), 2009 107
8.3 Electrophysiology Market, Mexico, Category Contribution (%), 2009 108
8.4 Electrophysiology Overall Revenue (2002-2016) 109
8.5 Electrophysiology Overall Volume (2002-2016) 111
8.6 Electrophysiology Average Price (2002-2016) 113
8.7 Electrophysiology Distribution Share (2008-2009) 114
8.8 Electrophysiology, Mexico, Company Share (2008-2009) 115

9 Interventional Cardiology In Mexico 117
9.1 Interventional Cardiology, Market Segmentation 117
9.2 Interventional Cardiology Market, Mexico, Revenue Mix ($m), 2009 118
9.3 Interventional Cardiology Market, Mexico, Category Contribution (%), 2009 119
9.4 Interventional Cardiology Overall Revenue (2002-2016) 120
9.4.1 Cardiac Catheter Revenue (2002-2016) 123
9.4.2 Coronary Stent Revenue (2002-2016) 125
9.4.3 PTCA Balloon Revenue (2002-2016) 127
9.5 Interventional Cardiology Overall Volume (2002-2016) 129
9.5.1 Cardiac Catheter Volume (2002-2016) 131
9.5.2 Coronary Stent Volume (2002-2016) 133
9.5.3 PTCA Balloon Volume (2002-2016) 135
9.6 Interventional Cardiology Average Price (2002-2016) 137
9.7 Interventional Cardiology Distribution Share (2008-2009) 139
9.8 Interventional Cardiology, Mexico, Company Share (2008-2009) 140

10 Peripheral Vascular Devices In Mexico 141
10.1 Peripheral Vascular Devices, Market Segmentation 141
10.2 Peripheral Vascular Devices Market, Mexico, Revenue Mix ($m), 2009 142
10.3 Peripheral Vascular Devices Market, Mexico, Category Contribution (%), 2009 143
10.4 Peripheral Vascular Peripheral Vascular Devices Overall Revenue (2002-2016) 144
10.5 Peripheral Vascular Devices Overall Volume (2002-2016) 148
10.6 Peripheral Vascular Devices Average Price (2002-2016) 152
10.7 Peripheral Vascular Devices Distribution Share (2008-2009) 153
10.8 Peripheral Vascular Devices, Mexico, Company Share (2008-2009) 154

11 Overview of Key Companies in Mexico Cardiovascular Devices Market 156
11.1 Boston Scientific Corporation 156
11.1.1 Company Overview 156
11.1.2 Share in the Mexico Cardiovascular Devices Market 156
11.2 Medtronic, Inc. 157
11.2.1 Company Overview 157
11.3 Share in the Mexico Cardiovascular Devices Market 157
11.4 Cordis Corporation 158
11.4.1 Company Overview 158
11.5 Share in the Mexico Cardiovascular Devices Market 158
11.6 St. Jude Medical, Inc. 159
11.6.1 Company Overview 159
11.7 Share in the Mexico Cardiovascular Devices Market 159
11.8 Abbott Laboratories 160
11.8.1 Company Overview 160
11.9 Share in the Mexico Cardiovascular Devices Market 160
11.10 Terumo Corporation 161
11.10.1 Company Overview 161
11.11 Share in the Mexico Cardiovascular Devices Market 161
11.12 Edwards Lifesciences Corporation 162
11.12.1 Company Overview 162
11.13 Share in the Mexico Cardiovascular Devices Market 162
11.14 Biosense Webster, Inc. 163
11.14.1 Company Overview 163
11.15 C. R. Bard, Inc. 163
11.15.1 Company Overview 163
11.16 Thoratec Corporation 164
11.16.1 Company Overview 164
11.17 GE Healthcare 164
11.17.1 Company Overview 164
11.18 Philips Healthcare 165
11.18.1 Company Overview 165
11.19 Datascope Corporation 165
11.19.1 Company Overview 165
11.20 Welch Allyn Inc. 165
11.20.1 Company Overview 165
11.21 Nihon Kohden Corporation 166
11.21.1 Company Overview 166
11.22 Fukuda Denshi Co., Ltd. 166
11.22.1 Company Overview 166
11.23 OSI Systems, Inc. 167
11.23.1 Company Overview 167
11.24 Sorin S.p.A. 167
11.24.1 Company Overview 167
11.25 BIOTRONIK SE & Co. KG 168
11.25.1 Company Overview 168
11.26 ABIOMED, Inc. 168
11.26.1 Company Overview 168
11.27 Cardiac Science Corporation 169
11.27.1 Company Overview 169
11.28 MAQUET GmbH & Co. KG 169
11.28.1 Company Overview 169
11.29 Cook Medical Incorporated 170
11.29.1 Company Overview 170
11.30 W. L. Gore & Associates, Inc. 170
11.30.1 Company Overview 170
11.31 ev3 Inc. 170
11.31.1 Company Overview 170

12 Cardiovascular DevicesMarket Pipeline Products 171

13 Financial Deals Landscape 182
13.1 Partnerships 182
13.1.1 Cardiac Network Signs Licensing Agreement With Pacific Innovations 182
13.1.2 BIOTRONIK Enters Into Exclusive Distribution Agreement With Endosense 183

14 Appendix 184
14.1 Definitions of Markets Covered in the Report 185
14.1.1 Cardiovascular Devices 185
14.2 Research Methodology 192
14.3 Secondary Research 193
14.4 Primary Research 193
14.5 Models 194
14.6 Forecasts 194
14.7 Expert Panels 194
14.8 GlobalData Consulting 194
14.9 Currency Conversion 195
14.10 Contact Us 195
14.11 Disclaimer 195

List of Tables

 
Table 1: Cardiovascular Devices, Mexico, Overall Revenue ($m), 2002-2016 18
Table 2: Cardiovascular Devices Market, Mexico, Category Contribution (%), 2009 20
Table 3: Cardiovascular Devices, Mexico, Cross-Category Analysis, 2002-2016 21
Table 4: Cardiovascular Devices, Mexico, Overall Revenue ($m), Historic, 2002-2009 23
Table 5: Cardiovascular Devices, Mexico, Overall Revenue ($m), Forecast, 2009-2016 25
Table 6: Cardiovascular Devices, Mexico, Category Volume (Units), 2002-2016 26
Table 7: Cardiovascular Devices, Mexico, Category Volume (Units), Historic, 2002-2009 28
Table 8: Cardiovascular Devices, Mexico, Category Volume (Units), Forecast, 2009-2016 30
Table 9: Cardiovascular Devices, Mexico, Company Share by Revenue ($m), 2008-2009 32
Table 10: Cardiac Rhythm Management Market, Mexico, Category Contribution (%), 2009 35
Table 11: Cardiac Rhythm Management, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 37
Table 12: Cardiac Rhythm Management, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 38
Table 13: Cardiac Resynchronisation Therapy, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Table 14: Cardiac Resynchronisation Therapy, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40
Table 15: Implantable Cardioverter Defibrillator, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 41
Table 16: Implantable Cardioverter Defibrillator, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 42
Table 17: Pacemaker, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 43
Table 18: Pacemaker, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 44
Table 19: External Defibrillator, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 45
Table 20: External Defibrillator, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 46
Table 21: Cardiac Rhythm Management, Mexico, Volume (Units) by Segment, Historic, 2002-2009 47
Table 22: Cardiac Rhythm Management, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 48
Table 23: Cardiac Resynchronisation Therapy, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 49
Table 24: Cardiac Resynchronisation Therapy, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 50
Table 25: Implantable Cardioverter Defibrillator, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 51
Table 26: Implantable Cardioverter Defibrillator, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 52
Table 27: Pacemaker, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 53
Table 28: Pacemaker, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 54
Table 29: External Defibrillator, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 55
Table 30: External Defibrillator, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 56
Table 31: Cardiac Rhythm Management, Mexico, Average Price ($), Historic, 2002-2009 57
Table 32: Cardiac Rhythm Management, Mexico, Average Price ($), Forecast, 2009-2016 58
Table 33: Cardiac Rhythm Management, Mexico, Distribution Share by Revenue ($m), 2008-2009 59
Table 34: Cardiac Rhythm Management, Mexico, Company Share by Revenue ($m), 2008-2009 61
Table 35: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Category Contribution (%), 2009 64
Table 36: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 66
Table 37: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 67
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Volume (Units) by Segment, Historic, 2002-2009 68
Table 39: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 69
Table 40: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Average Price ($), Historic, 2002-2009 70
Table 41: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Average Price ($), Forecast, 2009-2016 70
Table 42: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Distribution Share by Revenue ($m), 2008-2009 71
Table 43: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Company Share by Revenue ($m), 2008-2009 73
Table 44: Cardiovascular Prosthetic Devices Market, Mexico, Category Contribution (%), 2009 76
Table 45: Cardiovascular Prosthetic Devices, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 77
Table 46: Cardiovascular Prosthetic Devices, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 78
Table 47: Cardiac Assist Devices, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 79
Table 48: Cardiac Assist Devices, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80
Table 49: Prosthetic Heart Valve, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 81
Table 50: Prosthetic Heart Valve, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 82
Table 51: Cardiovascular Prosthetic Devices, Mexico, Volume (Units) by Segment, Historic, 2002-2009 83
Table 52: Cardiovascular Prosthetic Devices, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 84
Table 53: Cardiac Assist Devices, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 85
Table 54: Cardiac Assist Devices, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 86
Table 55: Prosthetic Heart Valve, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 87
Table 56: Prosthetic Heart Valve, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 88
Table 57: Cardiovascular Prosthetic Devices, Mexico, Average Price ($), Historic, 2002-2009 89
Table 58: Cardiovascular Prosthetic Devices, Mexico, Average Price ($), Forecast, 2009-2016 89
Table 59: Cardiovascular Prosthetic Devices, Mexico, Distribution Share by Revenue ($m), 2008-2009 90
Table 60: Cardiovascular Prosthetic Devices, Mexico, Company Share by Revenue ($m), 2008-2009 91
Table 61: Cardiovascular Surgery Market, Mexico, Category Contribution (%), 2009 94
Table 62: Cardiovascular Surgery, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 95
Table 63: Cardiovascular Surgery, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 96
Table 64: Perfusion Disposables, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 97
Table 65: Perfusion Disposables, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 98
Table 66: Cardiovascular Surgery, Mexico, Volume (Units) by Segment, Historic, 2002-2009 99
Table 67: Cardiovascular Surgery, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 100
Table 68: Perfusion Disposables, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 101
Table 69: Perfusion Disposables, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 102
Table 70: Cardiovascular Surgery, Mexico, Average Price ($), Historic, 2002-2009 103
Table 71: Cardiovascular Surgery, Mexico, Average Price ($), Forecast, 2009-2016 103
Table 72: Cardiovascular Surgery, Mexico, Distribution Share by Revenue ($m), 2008-2009 104
Table 73: Cardiovascular Surgery, Mexico, Company Share by Revenue ($m), 2008-2009 105
Table 74: Electrophysiology Market, Mexico, Category Contribution (%), 2009 108
Table 75: Electrophysiology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 109
Table 76: Electrophysiology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 110
Table 77: Electrophysiology, Mexico, Volume (Units) by Segment, Historic, 2002-2009 111
Table 78: Electrophysiology, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 112
Table 79: Electrophysiology, Mexico, Average Price ($), Historic, 2002-2009 113
Table 80: Electrophysiology, Mexico, Average Price ($), Forecast, 2009-2016 113
Table 81: Electrophysiology, Mexico, Distribution Share by Revenue ($m), 2008-2009 114
Table 82: Electrophysiology, Mexico, Company Share by Revenue ($m), 2008-2009 116
Table 83: Interventional Cardiology Market, Mexico, Category Contribution (%), 2009 119
Table 84: Interventional Cardiology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 121
Table 85: Interventional Cardiology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 122
Table 86: Cardiac Catheter, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 123
Table 87: Cardiac Catheter, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 124
Table 88: Coronary Stent, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 125
Table 89: Coronary Stent, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 126
Table 90: PTCA Balloon, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 127
Table 91: PTCA Balloon, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 128
Table 92: Interventional Cardiology, Mexico, Volume (Units) by Segment, Historic, 2002-2009 129
Table 93: Interventional Cardiology, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 130
Table 94: Cardiac Catheter, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 131
Table 95: Cardiac Catheter, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 132
Table 96: Coronary Stent, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 133
Table 97: Coronary Stent, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 134
Table 98: PTCA Balloon, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 135
Table 99: PTCA Balloon, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 136
Table 100: Interventional Cardiology, Mexico, Average Price ($), Historic, 2002-2009 137
Table 101: Interventional Cardiology, Mexico, Average Price ($), Forecast, 2009-2016 138
Table 102: Interventional Cardiology, Mexico, Distribution Share by Revenue ($m), 2008-2009 139
Table 103: Interventional Cardiology, Mexico, Company Share by Revenue ($m), 2008-2009 140
Table 104: Peripheral Vascular Devices Market, Mexico, Category Contribution (%), 2009 143
Table 105: Peripheral Vascular Devices, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 145
Table 106: Peripheral Vascular Devices, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 147
Table 107: Peripheral Vascular Devices, Mexico, Volume (Units) by Segment, Historic, 2002-2009 149
Table 108: Peripheral Vascular Devices, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 151
Table 109: Peripheral Vascular Devices, Mexico, Average Price ($), Historic, 2002-2009 152
Table 110: Peripheral Vascular Devices, Mexico, Average Price ($), Forecast, 2009-2016 152
Table 111: Peripheral Vascular Devices, Mexico, Distribution Share by Revenue ($m), 2008-2009 153
Table 112: Peripheral Vascular Devices, Mexico, Company Share by Revenue ($m), 2008-2009 155
Table 113: Cardiovascular DevicesMarket Pipeline Products 171
Table 114: Cardiac Network Signs Licensing Agreement With Pacific Innovations 182
Table 115: BIOTRONIK Enters Into Exclusive Distribution Agreement With Endosense 183
Table 116: USD to Local Currency, Mexico, Average Actual Rate 2002-2009 195

List of Figures

 
Figure 1: Cardiovascular Devices, Market Segmentation 17
Figure 2: Cardiovascular Devices, Mexico, Overall Revenue ($m), 2002-2016 18
Figure 3: Cardiovascular Devices Market, Mexico, Revenue Mix ($m), 2009 19
Figure 4: Cardiovascular Devices Market, Mexico, Category Contribution (%), 2009 20
Figure 5: Cardiovascular Devices, Mexico, Cross-Category Analysis, 2002-2016 21
Figure 6: Cardiovascular Devices, Mexico, Overall Revenue ($m), Historic, 2002-2009 22
Figure 7: Cardiovascular Devices, Mexico, Overall Revenue ($m), Forecast, 2009-2016 24
Figure 8: Cardiovascular Devices, Mexico, Category Volume (Units), 2002-2016 26
Figure 9: Cardiovascular Devices, Mexico, Category Volume (Units), Historic, 2002-2009 27
Figure 10: Cardiovascular Devices, Mexico, Category Volume (Units), Forecast, 2009-2016 29
Figure 11: Cardiovascular Devices, Mexico, Company Share (%), 2009 31
Figure 12: Cardiac Rhythm Management, Market Segmentation 33
Figure 13: Cardiac Rhythm Management Market, Mexico, Revenue Mix ($m), 2009 34
Figure 14: Cardiac Rhythm Management Market, Mexico, Category Contribution (%), 2009 35
Figure 15: Cardiac Rhythm Management, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 36
Figure 16: Cardiac Rhythm Management, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 38
Figure 17: Cardiac Resynchronisation Therapy, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Figure 18: Cardiac Resynchronisation Therapy, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40
Figure 19: Implantable Cardioverter Defibrillator, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 41
Figure 20: Implantable Cardioverter Defibrillator, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 42
Figure 21: Pacemaker, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 43
Figure 22: Pacemaker, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 44
Figure 23: External Defibrillator, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 45
Figure 24: External Defibrillator, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 46
Figure 25: Cardiac Rhythm Management, Mexico, Volume (Units) by Segment, Historic, 2002-2009 47
Figure 26: Cardiac Rhythm Management, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 48
Figure 27: Cardiac Resynchronisation Therapy, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 49
Figure 28: Cardiac Resynchronisation Therapy, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 50
Figure 29: Implantable Cardioverter Defibrillator, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 51
Figure 30: Implantable Cardioverter Defibrillator, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 52
Figure 31: Pacemaker, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 53
Figure 32: Pacemaker, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 54
Figure 33: External Defibrillator, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 55
Figure 34: External Defibrillator, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 56
Figure 35: Cardiac Rhythm Management, Mexico, Company Share (%), 2009 60
Figure 36: Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 62
Figure 37: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue Mix ($m), 2009 63
Figure 38: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Category Contribution (%), 2009 64
Figure 39: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 65
Figure 40: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 67
Figure 41: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Volume (Units) by Segment, Historic, 2002-2009 68
Figure 42: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 69
Figure 43: Cardiovascular Monitoring and Diagnostic Devices, Mexico, Company Share (%), 2009 72
Figure 44: Cardiovascular Prosthetic Devices, Market Segmentation 74
Figure 45: Cardiovascular Prosthetic Devices Market, Mexico, Revenue Mix ($m), 2009 75
Figure 46: Cardiovascular Prosthetic Devices Market, Mexico, Category Contribution (%), 2009 76
Figure 47: Cardiovascular Prosthetic Devices, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 77
Figure 48: Cardiovascular Prosthetic Devices, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 78
Figure 49: Cardiac Assist Devices, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 79
Figure 50: Cardiac Assist Devices, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80
Figure 51: Prosthetic Heart Valve, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 81
Figure 52: Prosthetic Heart Valve, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 82
Figure 53: Cardiovascular Prosthetic Devices, Mexico, Volume (Units) by Segment, Historic, 2002-2009 83
Figure 54: Cardiovascular Prosthetic Devices, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 84
Figure 55: Cardiac Assist Devices, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 85
Figure 56: Cardiac Assist Devices, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 86
Figure 57: Prosthetic Heart Valve, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 87
Figure 58: Prosthetic Heart Valve, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 88
Figure 59: Cardiovascular Prosthetic Devices, Mexico, Company Share (%), 2009 91
Figure 60: Cardiovascular Surgery, Market Segmentation 92
Figure 61: Cardiovascular Surgery Market, Mexico, Revenue Mix ($m), 2009 93
Figure 62: Cardiovascular Surgery Market, Mexico, Category Contribution (%), 2009 94
Figure 63: Cardiovascular Surgery, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 95
Figure 64: Cardiovascular Surgery, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 96
Figure 65: Perfusion Disposables, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 97
Figure 66: Perfusion Disposables, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 98
Figure 67: Cardiovascular Surgery, Mexico, Volume (Units) by Segment, Historic, 2002-2009 99
Figure 68: Cardiovascular Surgery, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 100
Figure 69: Perfusion Disposables, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 101
Figure 70: Perfusion Disposables, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 102
Figure 71: Cardiovascular Surgery, Mexico, Company Share (%), 2009 105
Figure 72: Electrophysiology, Market Segmentation 106
Figure 73: Electrophysiology Market, Mexico, Revenue Mix ($m), 2009 107
Figure 74: Electrophysiology Market, Mexico, Category Contribution (%), 2009 108
Figure 75: Electrophysiology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 109
Figure 76: Electrophysiology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 110
Figure 77: Electrophysiology, Mexico, Volume (Units) by Segment, Historic, 2002-2009 111
Figure 78: Electrophysiology, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 112
Figure 79: Electrophysiology, Mexico, Company Share (%), 2009 115
Figure 80: Interventional Cardiology, Market Segmentation 117
Figure 81: Interventional Cardiology Market, Mexico, Revenue Mix ($m), 2009 118
Figure 82: Interventional Cardiology Market, Mexico, Category Contribution (%), 2009 119
Figure 83: Interventional Cardiology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 120
Figure 84: Interventional Cardiology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 122
Figure 85: Cardiac Catheter, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 123
Figure 86: Cardiac Catheter, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 124
Figure 87: Coronary Stent, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 125
Figure 88: Coronary Stent, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 126
Figure 89: PTCA Balloon, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 127
Figure 90: PTCA Balloon, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 128
Figure 91: Interventional Cardiology, Mexico, Volume (Units) by Segment, Historic, 2002-2009 129
Figure 92: Interventional Cardiology, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 130
Figure 93: Cardiac Catheter, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 131
Figure 94: Cardiac Catheter, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 132
Figure 95: Coronary Stent, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 133
Figure 96: Coronary Stent, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 134
Figure 97: PTCA Balloon, Mexico, Volume (Units) by Sub-Segment, Historic, 2002-2009 135
Figure 98: PTCA Balloon, Mexico, Volume (Units) by Sub-Segment, Forecast, 2009-2016 136
Figure 99: Interventional Cardiology, Mexico, Company Share (%), 2009 140
Figure 100: Peripheral Vascular Devices, Market Segmentation 141
Figure 101: Peripheral Vascular Devices Market, Mexico, Revenue Mix ($m), 2009 142
Figure 102: Peripheral Vascular Devices Market, Mexico, Category Contribution (%), 2009 143
Figure 103: Peripheral Vascular Devices, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 144
Figure 104: Peripheral Vascular Devices, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 146
Figure 105: Peripheral Vascular Devices, Mexico, Volume (Units) by Segment, Historic, 2002-2009 148
Figure 106: Peripheral Vascular Devices, Mexico, Volume (Units) by Segment, Forecast, 2009-2016 150
Figure 107: Peripheral Vascular Devices, Mexico, Company Share (%), 2009 154
Figure 108: Boston Scientific Corporation, Company Share (%),Mexico Cardiovascular Devices Market, 2009 156
Figure 109: Medtronic, Inc., Company Share (%),Mexico Cardiovascular Devices Market, 2009 157
Figure 110: Cordis Corporation, Company Share (%),Mexico Cardiovascular Devices Market, 2009 158
Figure 111: St. Jude Medical, Inc., Company Share (%),Mexico Cardiovascular Devices Market, 2009 159
Figure 112: Abbott Laboratories, Company Share (%),Mexico Cardiovascular Devices Market, 2009 160
Figure 113: Terumo Corporation, Company Share (%),Mexico Cardiovascular Devices Market, 2009 161
Figure 114: Edwards Lifesciences Corporation, Company Share (%),Mexico Cardiovascular Devices Market, 2009 162
Figure 115: GlobalData Methodology 192

Upcoming Reports:

Influenza Vaccine Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecasts 2012 - 2018
By - Transparency Market Research
Influenza Vaccine is also called as flu shot and is used for protection against influenza virus. An influenza vaccine is a combination of three influenza viruses namely, influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain and influenza type B virus strain. Over the recent years, the Influenza Vaccine market has witnessed double digit growth rate due to fear of an impending pandemic. The Influenza Vaccine market has grown at a CAGR of approximately 65% between 2008 and 2010 due to the havoc caused by H1N1 virus. However, H1N1 flu vaccine...
Animal Therapeutics and Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The similarities in the structure and functioning of body parts in humans and in animals increases the size of the animal therapeutics and diagnostics market. The rising number of pet adoptions across the globe, rising incidences of chronic diseases such as bovine spongiform encephalopathy, rising global meat consumption, and the rising incidences of pet obesity, especially in developed countries such as the U.S., are some of the growth drivers for the market.  The global animal therapeutics and diagnostics market is segmented on the basis of products into...
Industrial Wireless Sensor Networks (IWSN) Market - Global Forecast And Analysis (2012 - 2017): By Technology, Components, Applications, Geography
By - Transparency Market Research
The industrial wireless sensor networks market is forecasted to grow and reach the market value of USD 3,975.38 million at the compounded annual growth rate of 15.59% by the year 2017. Growth of this market is driven by increasing use of wireless sensors in number of industrial applications like process automation, security, and supervisory control and data acquisition (SCADA). There are number of physical quantities required to be measured in the processing world. Some common parameters include temperature, pressure, level, and flow. Other wireless sensors used in manufacturing and...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...